I am a surgeon with extensive experience in hepatobiliary disease, particularly in patients with liver, bile duct, gallbladder, or pancreatic cancers. I also have a special expertise in biliary tract reconstruction.
There are some 20 surgeons, gastroenterologists, radiologists, pathologists, medical oncologists, and radiation oncologists working in the Hepatobiliary Disease Management Program. We all work closely as a team and meet frequently to determine the most appropriate treatment for each patient, review research, and organize the team to achieve the best possible care for patients.
Over the years, my clinical and research work has contributed to the understanding and management of diseases of the gastrointestinal tract and especially of the liver, biliary tract, and pancreas. My research has included studies on the surgical management of tumors of the gall bladder, bile ducts, and liver as well as the control of blood loss during major operations and the assessment of risk factors in patients undergoing major liver and biliary operations.
I have lectured extensively both in the United States and internationally and have published the leading international text on hepatobiliary surgery, which is now in its fifth edition.
- Clinical Expertise: General Surgical Oncology; Benign and Malignant Disease of the Liver and Bile Ducts; Pancreatic Cancer
- Languages Spoken: English
- Education: MD, University of Sheffield
- Residencies: Surgery - Royal Hospital of Sheffield
- Fellowships: Surgery - Nottingham General Hospital; - Sheffield Royal Infirmary
- Board Certifications: Surgery (U.K.)
Jarnagin WR, Belghiti J, Büchler MW, Chapman WC, D’Angelica MI, DeMatteo RP, Hann LE, Blumgart LH (eds). Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas, 5th ed. Philadelphia: Saunders Elsevier, 2012.
Blumgart LH. Video Atlas: Liver, Biliary & Pancreatic Surgery. Philadelphia: Saunders Elsevier, 2010.
Blumgart LH, Fong Y, Jarnagin WR (eds). Hepatobiliary Cancer: The American Cancer Society Atlas of Clinical Oncology. Hamilton, Ont: BC Decker, 2001.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more